ABOUT GLOBAL HEALTH INNOVATION
By investing in breakthrough health care innovations that are adjacent to Merck/MSD's core pharmaceuticals and vaccines business, Global Health Innovation (GHI) is at the vanguard of Merck/MSD's broadening focus on health and wellness.
Established in 2010 as a LLC, GHI deploys its evergreen $250 million fund to rapidly identify and develop transformative global health care opportunities.
Bill Taranto - Managing Director
Mr. Taranto is the Managing Director of the GHI Fund. Bill has over 25 years of health care experience with 12 years experience in adjacency health care investing. In addition to his experience in venture investing, Bill brings experience in evaluating new business models, sales and marketing operations, and investment banking.
Max Kahn - Investment Principal
Mr. Kahn is an Investment Principal responsible for identifying investment opportunities in emerging health care solutions and services, with a particular emphasis on solutions for ElderCare, Remote Monitoring, Wellness, and Transitions in Care. Max brings nearly 15 years of experience in pharmaceutical and health care business development. Max also brings strategy consulting and investment banking experience.
David Rubin - Investment Principal
Dr. Rubin is an Investment Principal responsible for identifying investment opportunities in emerging health care solutions and services, with a particular emphasis on solutions for Personalized Medicine and Point of Care Diagnostics. David brings over 20 years of health care experience rooted in deep science. In addition, David previously founded and ran a venture backed R&D software and content products company.
Dave Stevenson - Investment Principal
Mr. Stevenson is an Investment Principal responsible for identifying investment opportunities in emerging health care solutions and services, as well as overall responsibility for managing the GHI portfolio and operations. Dave brings over 20 years of healthcare strategy and innovation expertise to the GHI team. His experience includes operational roles with healthcare companies, in addition to a decade of strategy consulting experience.
Joe Volpe - Investment Principal
Mr. Volpe is an Investment Principal responsible for identifying investment opportunities in Health Information Technology. Joe has over 25 years of experience in health care innovation and health care investing. Joe brings a strong technical engineering background coupled with an in-depth understanding of emerging technologies in the health care industry.
